Patents-Review.com
ClassID:

96823 ⎘

C07K14/22 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)

Recent Application in this class:
#1
20260146067
2026-05-28

MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES

 #2
20260125718
2026-05-07

GENETICALLY MODIFIED STRAIN OF AUREOBASIDIUM PULLULANS AND USE THEREOF FOR PRODUCING BIOPRODUCT IN HIGH YIELD

 #3
20260124287
2026-05-07

NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF

 #4
20260097107
2026-04-09

MENINGOCOCCUS VACCINES

 #5
20260048113
2026-02-19

ADJUVANTED IMMUNOGENIC COMPOSITION AGAINST NEISSERIA MENINGITIDIS B

 #6
20250250307
2025-08-07

MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES

 #7
20250223319
2025-07-10

IMPROVED CHIMERIC POLYPEPTIDES AND USES THEREOF

 #8
20250222092
2025-07-10

PROTEIN NANOSTRUCTURE VACCINE

 #9
20250170232
2025-05-29

Vaccines for Neisseria Gonorrhoeae

 #10
20250154206
2025-05-15

Factor H Binding Protein Variants and Methods of Use Thereof

 #11
20250136648
2025-05-01

Factor H Binding Protein Variants and Methods of Use Thereof

 #12
20250092085
2025-03-20

SAPONIN-BASED ADJUVANTS AND VACCINES

 #13
20250064912
2025-02-27

VACCINES FOR NEISSERIA GONORRHOEAE

 #14
20240424079
2024-12-26

Vaccines targeting Neisseria gonorrhoeae

 #15
20240327470
2024-10-03

MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES

 #16
20240248100
2024-07-25

SEPTAPEPTIDES ASSOCIATED WITH NEURODEGENERACY

 #17
20240228551
2024-07-11

MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES

 #18
20240218026
2024-07-04

MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES

 #19
20240181029
2024-06-06

SLAM polynucleotides and polypeptides and uses thereof

 #20
20240132550
2024-04-25

Modified meningococcal fHbp polypeptides

 #21
20240101610
2024-03-28

Factor H binding protein variants and methods of use thereof

 #22
20240067982
2024-02-29

RNA-DIRECTED DNA CLEAVAGE AND GENE EDITING BY CAS9 ENZYME FROM NEISSERIA MENINGITIDIS

 #23
20240026415
2024-01-25

NMR METHODS AND SYSTEMS FOR THE RAPID DETECTION OF BACTERIA

 #24
20240025951
2024-01-25

Factor H binding protein variants and methods of use thereof

 #25
20230414737
2023-12-28

NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF

 #26
20230414736
2023-12-28

MENINGOCOCCUS VACCINES

 #27
20230203091
2023-06-29

Glycoconjugation process

 #28
20230183298
2023-06-15

CARRIER PROTEIN SUBJECTED TO SITE-DIRECTED MUTATION AND USE THEREOF IN PREPARATION OF VACCINE

 #29
20230181709
2023-06-15

IMMUNOGENIC PROTEIN AGAINST GONOCOCCAL INFECTION

 #30
20230137914
2023-05-04

nOMV-ANTIGEN CONJUGATED COMPOUNDS AND USE THEREOF

 #31
20230106353
2023-04-06

SYSTEM FOR COVALENTLY LINKING PROTEINS

 #32
20230019488
2023-01-19

NEISSERIA MENINGITIDIS IMMUNOGENIC COMPOSITIONS

 #33
20220401544
2022-12-22

NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF

 #34
20220395567
2022-12-15

MULTI-ANTIGENIC PEPTIDE MIMICS OF GONOCOCCAL LIPO-OLIGOSACCHARIDE (LOS) EPITOPES

 #35
20220257751
2022-08-18

QUANTIFICATION OF BIOCONJUGATE GLYCOSYLATION

 #36
20220137051
2022-05-05

IN-VITRO POTENCY ASSAY FOR PROTEIN-BASED MENINGOCOCCAL VACCINES

 #37
20220112249
2022-04-14

MODIFIED FACTOR H BINDING PROTEIN

 #38
20220089655
2022-03-24

NOVEL POLYPEPTIDE-MODIFYING ENZYMES AND USES THEREOF

 #39
20220054632
2022-02-24

MODIFIED CARRIER PROTEINS FOR O-LINKED GLYCOSYLATION

 #40
20220047697
2022-02-17

SALMONELLA VACCINE FOR THE TREATMENT OF CORONAVIRUS

 #41
20220002355
2022-01-06

Modified meningococcal fHbp polypeptides

 #42
20210379176
2021-12-09

SLAM polynucleotides and polypeptides and uses thereof

 #43
20210371453
2021-12-02

Glycoconjugation process

 #44
20210340191
2021-11-04

Factor H binding protein variants and methods of use thereof

 #45
20210308247
2021-10-07

GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by

#46
20210277069
2021-09-09

Modified meningococcal FHBP polypeptides

 #47
20210253647
2021-08-19

Modified meningococcal fHbp polypeptides

 #48
20210140980
2021-05-13

SEPTAPEPTIDES ASSOCIATED WITH NEURODEGENERACY

 #49
20210101943
2021-04-08

compositions and methods thereof

 #50
20210101942
2021-04-08

Factor H binding protein variants and methods of use thereof

 #51
20210085773
2021-03-25

NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF

 #52
20210024589
2021-01-28

composition and methods thereof

 #53
20200405838
2020-12-31

compositions and methods thereof

 #54
20200360503
2020-11-19

immunogenic compositions

 #55
20200331959
2020-10-22

Glycoconjugation process

 #56
20200319184
2020-10-08

Vitro potency assay for protein-based meningococcal vaccines

 #57
20200197308
2020-06-25

Surface display of antigens on Gram-negative outer membrane vesicles

 #58
20200164056
2020-05-28

compositions and methods thereof

 #59
20200138933
2020-05-07

Immunogenic compositions for the prevention and treatment of meningococcal disease

 #60
20200138932
2020-05-07

Regimens for immunisation with meningococcal conjugates

 #61
20200138931
2020-05-07

GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by

#62
20200123206
2020-04-23

composition and methods thereof

 #63
20200109179
2020-04-09

Factor H binding protein variants and methods of use thereof

 #64
20200095288
2020-03-26

Factor H binding protein variants and methods of use thereof

 #65
20200093914
2020-03-26

Non-lipidated variants of ORF2086 antigens

 #66
20200016258
2020-01-16

Targets of

#67
20200002408
2020-01-02

Recombinant gram negative bacteria and methods of generating and utilizing same

 #68
20200000907
2020-01-02

Factor H binding proteins (fHbp) with altered properties and methods of use thereof

 #69
20190389927
2019-12-26

CD147 AS RECEPTOR FOR PILUS-MEDIATED ADHESION OF MENINGOCOCCI TO VASCULAR ENDOTHELIA

 #70
20190330265
2019-10-31

Glycoconjugation process

 #71
20190315812
2019-10-17

Modified meningococcal FHBP polypeptides

 #72
20190282684
2019-09-19

Vaccines for

#73
20190262374
2019-08-29

Compositions and methods for treating bacterial disease

 #74
20190231861
2019-08-01

compositions and methods thereof

 #75
20190225655
2019-07-25

Factor H binding protein variants and methods of use thereof

 #76
20190211066
2019-07-11

VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS

 #77
20190183999
2019-06-20

DEVELOPMENTS IN MENINGOCOCCAL OUTER MEMBRANE VESICLES

 #78
20190151431
2019-05-23

IMMUNOGENIC COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MENINGOCOCCAL DISEASE

 #79
20190127426
2019-05-02

composition and methods thereof

 #80
20190117756
2019-04-25

Immunogenic Compositions and Vaccines Derived From Bacterial Surface Receptor Proteins

 #81
20190111122
2019-04-18

SLAM polynucleotides and polypeptides and uses thereof

 #82
20190077837
2019-03-14

Gonorrheal MtrE peptides and vaccines

 #83
20190071707
2019-03-07

NMR methods and systems for the rapid detection of bacteria

 #84
20190016761
2019-01-17

Compositions and vaccines comprising vesicles and methods of using the same

 #85
20190008943
2019-01-10

VACCINE

 #86
20190000955
2019-01-03

Targets of

#87
20180371030
2018-12-27

composition and methods thereof

 #88
20180369356
2018-12-27

GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by

#89
20180353587
2018-12-13

Immunogenic compositions containing bacterial outer membrane vesicles and therapeutic uses thereof

 #90
20180327457
2018-11-15

Industrially scalable process for recovering biologically active recombinant carrier proteins

 #91
20180243395
2018-08-30

Injectable vaccines against multiple meningococcal serogroups

 #92
20180214535
2018-08-02

Targets of acinetobacter baumannii

 #93
20180214534
2018-08-02

Targets of acinetobacter baumannii

 #94
20180214533
2018-08-02

Targets of

#95
20180214532
2018-08-02

compositions and methods thereof

 #96
20180214531
2018-08-02

Meningococcus vaccines

 #97
20180207256
2018-07-26

Targets of

#98
20180196047
2018-07-12

Strings of epitopes useful in diagnosing and eliciting immune responses to sexually transmitted infections

 #99
20180193445
2018-07-12

Targets of

#100
20180193444
2018-07-12

Targets of

#101
20180153808
2018-06-07

Surface display of antigens on gram-negative outer membrane vesicles

 #102
20180125962
2018-05-10

Factor H binding proteins (FHBP) with altered properties and methods of use thereof

 #103
20180125960
2018-05-10

MENINGITIDIS VACCINES COMPRISING SUBTILINASES

 #104
20180125959
2018-05-10

Compositions comprising proteins

 #105
20180064801
2018-03-08

Vaccines for

#106
20180037612
2018-02-08

VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS

 #107
20180028641
2018-02-01

Multiple variants of meningococcal protein NMB1870

 #108
20180022783
2018-01-25

compositions and methods thereof

 #109
20180009852
2018-01-11

Immunogenic bacterial vesicles with outer membrane proteins

 #110
20180000923
2018-01-04

compositions and methods thereof

 #111
20170326222
2017-11-16

Non-lipidated variants of ORF2086 antigens

 #112
20170304425
2017-10-26

Targets of acinetobacter baumannii

 #113
20170304372
2017-10-26

Compositions and methods for treating gonorrhea

 #114
20170290902
2017-10-12

MULTIPLE VARIANTS OF MENINGOCOCCAL PROTEIN NMB1870

 #115
20170252699
2017-09-07

ULTRAFILTRATION FOR PREPARING OUTER MEMBRANE VESICLES

 #116
20170252424
2017-09-07

Methods and compositions for vaccinating a subject for a sexually transmitted pathogen

 #117
20170226161
2017-08-10

Modified meningococcal fHbp polypeptides

 #118
20170183384
2017-06-29

Factor H binding protein variants and methods of use thereof

 #119
20170173140
2017-06-22

Immunogenic compositions for the prevention and treatment of meningococcal disease

 #120
20170065699
2017-03-09

GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by

#121
20170043004
2017-02-16

Capsular polysaccharide solubilisation and combination vaccines

 #122
20170037440
2017-02-09

Means and methods for producing capsular polysaccharides of low dispersity

 #123
20170008933
2017-01-12

Modified meningococcal fHbp polypeptides

 #124
20170000874
2017-01-05

Meningococcal conjugate vaccine for groups A, C, Y and W135 and a preparation method thereof

 #125
20160361406
2016-12-15

Acinetobacter baumannii antigens and the uses thereof

 #126
20160354457
2016-12-08

Injectable vaccines against multiple meningococcal serogroups

 #127
20160347797
2016-12-01

composition and methods thereof

 #128
20160303217
2016-10-20

Immunogenic compositions and vaccines derived from bacterial surface receptor proteins

 #129
20160289725
2016-10-06

High-cell density fed-batch fermentation process for producing recombinant protein

 #130
20160289276
2016-10-06

Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof

 #131
20160235833
2016-08-18

Chimeric Factor H Binding Proteins (fHBP) and Methods of Use

 #132
20160199476
2016-07-14

Developments in meningococcal outer membrane vesicles

 #133
20160185827
2016-06-30

VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS

 #134
20160175422
2016-06-23

Combination neisserial compositions

 #135
20160159865
2016-06-09

Non-naturally occurring factor H binding proteins (fHbp) and methods of use thereof

 #136
20160137702
2016-05-19

GAS57 MUTANT ANTIGENS AND GAS57 ANTIBODIES

 #137
20160108094
2016-04-21

Immunogenic bacterial vesicles with outer membrane proteins

 #138
20160041169
2016-02-11

Strings of epitopes useful in diagnosing and eliciting immune responses to sexually transmitted infections

 #139
20160039887
2016-02-11

Multiple variants of meningococcal protein NMB1870

 #140
20160031947
2016-02-04

Cupredoxin derived transport agents and methods of use thereof

 #141
20160030545
2016-02-04

NEISSERIA MENINGITIDIS ANTIGENS AND COMPOSITIONS

 #142
20160030544
2016-02-04

IMMUNOGENIC COMPOSITION TO NEISSERIA

 #143
20160030543
2016-02-04

Neisseria meningitidis compositions and methods thereof

 #144
20160017006
2016-01-21

Immunogenic fusion polypeptides

 #145
20150374780
2015-12-31

Compositions and methods to prevent cancer with cupredoxins

 #146
20150352160
2015-12-10

Therapeutic compositions and methods for treating infections

 #147
20150335724
2015-11-26

Immunogenic compositions for the prevention and treatment of meningococcal disease

 #148
20150328328
2015-11-19

Glycoconjugation process

 #149
20150299750
2015-10-22

Production of high yields of bacterial polysaccharides

 #150
20150291666
2015-10-15

Gonorrheal MtrE peptides and vaccines

 #151
20150290312
2015-10-15

GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by

#152
20150273044
2015-10-01

METHODS OF INDUCING AN IMMUNE RESPONSE WITH COMPOSITIONS COMPRISING A NEISSERIA MENINGITIDIS 741 PROTEIN

 #153
20150252388
2015-09-10

Increased ethanol production by genetic engineering of microorganisms to express hemoglobin

 #154
20150218566
2015-08-06

Promoters for increased protein expression in meningococcus

 #155
20150216960
2015-08-06

Immunogenic compositions for the prevention and treatment of meningococcal disease

 #156
20150190494
2015-07-09

fHbp variant and its use for vaccination

 #157
20150110806
2015-04-23

CD147 as receptor for pilus-mediated adhesion of to vascular endothelia

 #158
20150087806
2015-03-26

Glycopeptide and uses thereof

 #159
20150086582
2015-03-26

antigens and compositions

 #160
20150079124
2015-03-19

antigens and compositions

 #161
20150071959
2015-03-12

compositions and methods thereof

 #162
20150023999
2015-01-22

Targets of

#163
20140363462
2014-12-11

Heterologous expression of Neisserial proteins

 #164
20140356415
2014-12-04

Compositions and vaccines comprising vesicles and methods of using the same

 #165
20140348869
2014-11-27

MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES

 #166
20140336366
2014-11-13

BIOCONJUGATE VACCINES MADE IN PROKARYOTIC CELLS

 #167
20140335584
2014-11-13

Increased ethanol production by genetic engineering of microorganisms to express hemoglobin

 #168
20140335092
2014-11-13

COMPOSITIONS AND METHODS FOR IMMUNIZATION AGAINST DRUG RESISTANT ACINETOBACTER BAUMANNII

 #169
20140322254
2014-10-30

POLYPEPTIDE ADJUVANT

 #170
20140298538
2014-10-02

AXMI205 variant proteins and methods of use

 #171
20140294886
2014-10-02

Methods of inducing an immune response with compositions comprising a 741 protein

 #172
20140294885
2014-10-02

HETEROLOGOUS EXPRESSION OF NEISSERIAL PROTEINS

 #173
20140294884
2014-10-02

Meningococcus adhesins NadA, App and ORF 40

 #174
20140287990
2014-09-25

COMPOSITIONS AND METHODS TO CONCURRENTLY TREAT AND/OR PREVENT MULTIPLE DISEASES WITH CUPREDOXINS

 #175
20140234374
2014-08-21

Compositions and methods for activating innate and allergic immunity

 #176
20140220632
2014-08-07

Engineered sequences to facilitate expression of antigens in and methods of use

 #177
20140212473
2014-07-31

Glycopeptide and uses thereof

 #178
20140212449
2014-07-31

POLYPEPTIDE-VACCINES FOR BROAD PROTECTION AGAINST HYPERVIRULENT MENINGOCOCCAL LINEAGES

 #179
20140113329
2014-04-24

High-cell density fed-batch fermentation process for producing recombinant protein

 #180
20140056820
2014-02-27

Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof

 #181
20140051837
2014-02-20

AXMI-205 pesticidal gene and method for its use

 #182
20140050731
2014-02-20

Vaccine

 #183
20140046049
2014-02-13

AXMI-205 pesticidal gene and method for its use

 #184
20140037554
2014-02-06

Cupredoxin derived transport agents and methods of use thereof

 #185
20130296222
2013-11-07

Bacterium and extracts of said bacterium and the use of same in therapy

 #186
20130243807
2013-09-19

compositions and methods thereof

 #187
20130236489
2013-09-12

Developments in meningococcal outer membrane vesicles

 #188
20130217859
2013-08-22

Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870

 #189
20130196901
2013-08-01

porin proteins

 #190
20130171194
2013-07-04

Stable formulations of rLP2086 antigens

 #191
20130136762
2013-05-30

MODIFIED SURFACE ANTIGEN

 #192
20130115238
2013-05-09

Meningococcal fHBP polypeptides

 #193
20130085262
2013-04-04

NOVEL SURFACE ANTIGEN

 #194
20130084247
2013-04-04

Compositions and methods to prevent cancer with cupredoxins

 #195
20130064846
2013-03-14

NEISSERIAL ANTIGENS

 #196
20130045231
2013-02-21

Immunogenic composition

 #197
20130022633
2013-01-24

MENINGOCOCCAL fHBP POLYPEPTIDES

 #198
20130011429
2013-01-10

IMMUNOGENIC COMPOSITION

 #199
20130011338
2013-01-10

Cupredoxin derived transport agents and methods of use thereof

 #200
20130005667
2013-01-03

Heterologous expression of neisserial proteins

 #201
20130005030
2013-01-03

Nucleic acids encoding GAS57 mutant antigens

 #202
20130004530
2013-01-03

VACCINE COMPOSITION

 #203
20130004510
2013-01-03

Vaccine

 #204
20130004431
2013-01-03

Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof

 #205
20120328622
2012-12-27

Compounds

 #206
20120308595
2012-12-06

Novel Immunogenic Compositions For The Prevention And Treatment of Meningococcal Disease

 #207
20120302509
2012-11-29

Compositions and methods to prevent cancer with cupredoxins

 #208
20120301496
2012-11-29

Immunogenic compositions for the prevention and treatment of meningococcal disease

 #209
20120301474
2012-11-29

Compositions and methods for immunization against drug resistant

#210
20120294880
2012-11-22

Immunogenic compositions for the prevention and treatment of meningococcal disease

 #211
20120288517
2012-11-15

Factor H binding proteins (FHBP) with altered properties and methods of use thereof

 #212
20120283413
2012-11-08

Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870

 #213
20120276140
2012-11-01

Compositions and methods for activating innate and allergic immunity

 #214
20120276129
2012-11-01

Neisserial antigenic peptides

 #215
20120276120
2012-11-01

T-cell stimulating protein B and methods of use

 #216
20120219578
2012-08-30

Neisserial antigenic peptides

 #217
20120201844
2012-08-09

Immunogenic compositions for the prevention and treatment of meningococcal disease

 #218
20120195919
2012-08-02

Isolated protein and compositions comprising the protein

 #219
20120164166
2012-06-28

antigens and compositions

 #220
20120156236
2012-06-21

NEISSERIA MENINGITIDIS ANTIGENS AND COMPOSITIONS

 #221
20120148618
2012-06-14

MULTIPLE VARIANTS OF MENINGOCOCCAL PROTEIN NMB1870

 #222
20120148617
2012-06-14

Multiple variants of meningococcal protein NBM1870

 #223
20120148616
2012-06-14

antigens and compositions

 #224
20120135026
2012-05-31

COMBINATION NEISSERIAL COMPOSITIONS

 #225
20120135024
2012-05-31

antigens and compositions

 #226
20120123093
2012-05-17

NOVEL SURFACE ANTIGEN

 #227
20120121646
2012-05-17

Vaccine

 #228
20120121637
2012-05-17

Chimeric factor H binding proteins (fHbp) and methods of use

 #229
20120107339
2012-05-03

Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use

 #230
20120093867
2012-04-19

GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by

#231
20120093852
2012-04-19

Non-lipidated variants of ORF2086 antigens

 #232
20120070457
2012-03-22

Polypeptides from neisseria meningitidis

 #233
20120070456
2012-03-22

POLYPEPTIDE CARRIER PROTEIN

 #234
20120064120
2012-03-15

NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS

 #235
20120064119
2012-03-15

NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS

 #236
20120046458
2012-02-23

Method for the producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose

 #237
20120046456
2012-02-23

Method for the producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose

 #238
20120041179
2012-02-16

Preparation and purification of subunit vaccine for (NM) group B isolates

 #239
20120039984
2012-02-16

GLYCOPEPTIDE AND USES THEREOF

 #240
20120039942
2012-02-16

Outer membrane vesicles and uses thereof

 #241
20120034261
2012-02-09

NOVEL IMMUNOGENIC COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MENINGOCOCCAL DISEASE

 #242
20120027801
2012-02-02

Polypeptides from

#243
20120027800
2012-02-02

NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS

 #244
20110318378
2011-12-29

Peptides presenting an epitope of a domain of factor H binding protein and methods of use

 #245
20110313026
2011-12-22

DNA and proteins or peptides specific of bacteria of the species, methods for obtaining them and biological applications thereof

 #246
20110275146
2011-11-10

FUSION PROTEINS COMPRISING DP-178 AND OTHER VIRAL FUSION INHIBITOR PEPTIDES USEFUL FOR TREATING AIDS

 #247
20110269200
2011-11-03

Increased ethanol production by genetic engineering of microorganisms to express hemoglobin

 #248
20110262476
2011-10-27

Mutant bacterial glycoproteins and uses thereof

 #249
20110256180
2011-10-20

Factor H binding proteins (FHBP) with altered properties and methods of use thereof

 #250
20110250223
2011-10-13

Hybrid and tandem expression of proteins

 #251
20110243980
2011-10-06

Methods and systems for -glycosylating proteins

 #252
20110229522
2011-09-22

Methods, compositions and vaccines relating to antibodies

 #253
20110189215
2011-08-04

Vaccine comprising protein NMB0964 from

#254
20110189187
2011-08-04

Immunogenic compositions for the prevention and treatment of meningococcal disease

 #255
20110182981
2011-07-28

GONOCOCCAL VACCINES

 #256
20110171234
2011-07-14

Vaccine

 #257
20110166323
2011-07-07

Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870

 #258
20110136184
2011-06-09

METHOD FOR PRODUCING ALPHA-1, 6-BRANCHED ALPHA-1, 4-GLUCANS FROM SUCROSE

 #259
20110136183
2011-06-09

METHOD FOR PRODUCING ALPHA-1, 6-BRANCHED ALPHA-1, 4-GLUCANS FROM SUCROSE

 #260
20110110967
2011-05-12

GAS57 mutant antigens and GAS57 antibodies

 #261
20110104193
2011-05-05

COMBINATION NEISSERIAL COMPOSITIONS

 #262
20110077387
2011-03-31

Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof

 #263
20110076300
2011-03-31

Hybrid Polypeptides Including Meningococcal fHBP Sequences

 #264
20110076299
2011-03-31

Immunogenic compositions for the prevention and treatment of meningococcal disease

 #265
20110033500
2011-02-10

Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-neisseria meningitidis

 #266
20110033491
2011-02-10

Multicomponent meningococcal vaccine

 #267
20110023184
2011-01-27

AXMI-205 pesticidal gene and methods for its use

 #268
20110020390
2011-01-27

Meningococcal fHBP polypeptides

 #269
20100331537
2010-12-30

NOVEL SURFACE ANTIGEN

 #270
20100316675
2010-12-16

Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them

 #271
20100291680
2010-11-18

METHODS AND COMPOSITIONS FOR INHIBITION OF MEMBRANE FUSION-ASSOCIATED EVENTS, INCLUDING HIV TRANSMISSION

 #272
20100291608
2010-11-18

Crystal of GTP Cyclohydrolase Type IB

 #273
20100291137
2010-11-18

METHOD FOR REFOLDING NEISSERIAL NSPA PROTEIN

 #274
20100286384
2010-11-11

Replikin peptides in rapid replication of glioma cells and in influenza epidemics

 #275
20100278860
2010-11-04

System and method for identifying complex patterns of amino acids

 #276
20100272744
2010-10-28

OMP85 Proteins of Neisseria Gonorrhoeae and Neisseria Meningitidis, Compositions Containing Same and Methods of Use Thereof

 #277
20100272725
2010-10-28

Neisserial antigens

 #278
20100267931
2010-10-21

Heterologous expression of Neisserial proteins

 #279
20100240876
2010-09-23

REPLIKINS AND METHODS OF IDENTIFYING REPLIKIN-CONTAINING SEQUENCES

 #280
20100221256
2010-09-02

MENINGOCOCCUS ADHESINS NADA, APP AND ORF 40

 #281
20100215680
2010-08-26

REPLIKIN PEPTIDES AND ANTIBODIES THEREFOR

 #282
20100209355
2010-08-19

Cupredoxin derived transport agents and methods of use thereof

 #283
20100203057
2010-08-12

NOVEL COMPOUNDS

 #284
20100196409
2010-08-05

BASB006 POLYPEPTIDES FROM NEISSERIA MENINGITIDIS AND IMMUNOGENIC COMPOSITIONS THEREOF

 #285
20100189737
2010-07-29

Meningococcal vaccines including hemoglobin receptor

 #286
20100184639
2010-07-22

Nucleic acids and polypeptides specific of the genus pathogenic strains

 #287
20100184139
2010-07-22

BASB082 polynucleotides

 #288
20100166785
2010-07-01

Adjuvants

 #289
20100129387
2010-05-27

PHARMACEUTICAL COMPOSITION CONTAINING THE NMB0606 PROTEIN

 #290
20100087377
2010-04-08

Compositions and methods to prevent cancer with cupredoxins

 #291
20100047287
2010-02-25

Outer membrane vesicles and uses thereof

 #292
20100041868
2010-02-18

Conserved Neisserial antigens

 #293
20100016560
2010-01-21

Vaccine

 #294
20100015212
2010-01-21

Immunogenic bacterial vesicles with outer membrane proteins

 #295
20100015175
2010-01-21

Vaccine

 #296
20100015151
2010-01-21

Polypeptides from

#297
20100010211
2010-01-14

Vaccine

 #298
20100010210
2010-01-14

Vaccine

 #299
20100003283
2010-01-07

Lipid a deficient mutants of

#300
20090324639
2009-12-31

COMPOSITIONS AND METHODS FOR ACTIVATING INNATE AND ALLERGIC IMMUNITY